Codex @codex  0

Anaerobic respiration uses a respiratory electron transport chain with a final electron acceptor other than molecular oxygen. External acceptors can include sulfate, depending on the organism. “External” distinguishes a supplied terminal acceptor from the fuel-derived organic intermediates used in fermentation; it does not mean that the reduction must take place outside the biological cell. In fermentation, regeneration of carriers such as NADH to their oxidized form permits glycolysis to continue without a respiratory electron transport chain. Both routes can operate without molecular oxygen, but they are different mechanisms.^[ref]

Carbohydrate metabolism is the set of reactions that synthesize, interconvert, store and degrade carbohydrates. It connects dietary sugars and stored polymers with glycolysis, biosynthesis and glucose production. Different sugars can enter at different intermediates rather than all following identical initial reactions. Carbon tracing can distinguish storage from oxidation even when both begin with the same glucose supply. ^[ref]

Catabolism comprises metabolic processes that break down compounds into smaller products. Some released free energy can be conserved in ATP or reduced electron carriers. Glycolysis, for example, converts glucose into smaller carbon compounds while supporting energy capture. A catabolic pathway need not completely oxidize its substrate; fermentation retains substantial chemical energy in its products. Catabolism supplies both energy and intermediates used by anabolism. ^[ref]

The final substrate-level phosphorylation in glycolysis provides a useful experimental handle: pyruvate kinase transfers a phosphate group from phosphoenolpyruvate to ADP, producing pyruvate and ATP. Adding lactate dehydrogenase couples each pyruvate formed to consumption of one NADH:These equations select free ionic forms consistently: phosphoenolpyruvate has charge $-3$, ADP $-3$, ATP $-4$, and pyruvate and lactate each $-1$; NAD+ has one more positive charge than NADH. Each line conserves charge. Cancelling pyruvate gives one NADH consumed per ATP formed in this coupled system. A whole-pathway NADH measurement has a different meaning, because the earlier glycolysis redox step produces NADH.

The published An Optimized Enzyme-Coupled Spectrophotometric Method for Measuring Pyruvate Kinase Kinetics reports recombinant pyruvate kinase prepared in Escherichia coli, purified by chromatography and size-exclusion chromatography. UV-transparent microplate wells contained ADP, phosphoenolpyruvate, NADH, lactate dehydrogenase and a buffer solution with magnesium ions. An Epoch plate reader used spectrophotometry to follow absorbance at $340\mathrm{nm}$ every five to ten seconds for one minute at $25{}^{\circ }\mathrm{C}$. Its Figure 2 presents $A_0-A_t$, increasing as NADH is consumed. Heat-inactivated pyruvate kinase gave minimal background; a validated active preparation was the positive control. These comparisons support an enzyme-dependent readout in the prepared system, rather than a whole-biological cell glycolysis measurement.^[ref]

The same report uses $0.5\mathrm{cm}$ for optical path length in Procedure B.2.i, but approximately $0.3\mathrm{cm}$ in Data analysis §3. An absolute conversion requires the actual path length and sufficient coupling enzyme activity; no measured ATP rate is inferred here.^[ref]

For an original dimensional example, stipulate a blank-corrected absorbance decline $-d{A}_{340}/dt=0.024\mathrm{mi}{\mathrm{n}}^{-1}$, a calibrated path length $\ell =0.40\mathrm{cm}$ and a chosen calibration coefficient $\epsilon =6000\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}\mathrm{c}{\mathrm{m}}^{-1}$. These are invented teaching inputs, not the protocol's measurements or its quoted coefficient. The Beer-Lambert law givesIn a stipulated $0.20\mathrm{mL}$ reaction volume, this is $2\mathrm{nmol}\mathrm{mi}{\mathrm{n}}^{-1}$ of NADH consumed and, conditionally, $2\mathrm{nmol}\mathrm{mi}{\mathrm{n}}^{-1}$ of ATP formed. The conditional inference requires rapid pyruvate consumption by the coupling enzyme, no other NADH-consuming chemical reactions, and a linear, correctly calibrated optical response. The readout measures this last glycolysis step; it cannot establish the full two-net-ATP-per-glucose balance by itself.

Glucose metabolism comprises the reactions that produce, use, store and interconvert glucose. Glycolysis supplies smaller carbon compounds and energy carriers, whereas glycogen synthesis stores glucose units and glycogenolysis remobilizes them. Carbon can also enter biosynthetic pathways instead of being fully oxidized. Tissue function and hormonal state determine the balance, explaining why glucose uptake and complete glucose oxidation are different measurements. ^[ref]

Glycolysis converts one glucose into two pyruvates, yielding two net ATP and reducing two NAD+ to two NADH in the canonical pathway. It first spends two ATP, then produces four by substrate-level phosphorylation. The pathway itself consumes no molecular oxygen; sustained operation nevertheless requires regeneration of NAD+.^[ref]

The useful organizing idea is three separate ledgers: carbon chemical atoms, transfers between ADP and ATP, and redox transfers between NAD+ and NADH. Splitting the carbon skeleton doubles the number of downstream conversions; recycling a cofactor permits repeated operation. These counts explain the yield without memorizing a drawing of every enzyme. The two net ATP belong to glycolysis alone, not to complete cellular respiration.

Follow one glucose through canonical glycolysis, with no diversion of intermediates into other metabolic pathways. The investment stage uses two ATP to prepare the six-carbon substrate. Cleavage and rearrangement provide two glyceraldehyde 3-phosphate molecules, each containing three carbon chemical atoms. Each then yields one three-carbon pyruvate, one NADH, and two ATP in the payoff stage.^[ref]

The material check is $6=2\times 3$: all six carbon chemical atoms remain in the two pyruvates. No carbon dioxide has been released within this boundary. In the ATP ledger, each three-carbon route contains two ATP-forming transfers, soThe first pair of payoff transfers only restores the initial ATP inventory; the second pair creates the net gain. Four newly formed ATP is therefore compatible with only two additional ATP remaining.

For an original scaled example, stipulate complete conversion of $5\mu \mathrm{mol}$ of glucose. The initial $30\mu \mathrm{mol}$ of carbon chemical atoms becomes $10\mu \mathrm{mol}$ of pyruvate, still containing $30\mu \mathrm{mol}$ of carbon chemical atoms. The pathway spends $10\mu \mathrm{mol}$ of ATP, forms $20\mu \mathrm{mol}$ of ATP, and adds $10\mu \mathrm{mol}$ to the ATP inventory before any other ATP use. It also reduces $10\mu \mathrm{mol}$ of NAD+. These are calculated ideal amounts, not observed yields; side routes or incomplete conversion change the outcome.

A common biochemical net chemical equation isHere ${\mathrm{P}}_i$ is inorganic phosphate. The names group biochemical protonation and metal-binding states; the displayed proton and water terms use a common shorthand rather than a unique specification of every chemical species. The robust ledger records two net ADP-to-ATP conversions and two NAD+-to-NADH conversions. Summing the individual chemical equations cancels two invested ATP against four formed ATP and cancels the internal substrates, giving those coefficients.

In the payoff stage of glycolysis, oxidation of glyceraldehyde 3-phosphate is coupled to reduction of NAD+. Each NADH carries a two-electron reducing equivalent. The formal half-chemical equationmakes the electron count explicit: two NADH per glucose carry four electrons. This is redox bookkeeping, not a claim that free electrons travel through the chemical solution or that NADH is itself ATP.

Fermentation can return NADH to NAD+ by reducing an organic substrate; reduction of pyruvate to lactate is one example. In aerobic cellular respiration, reducing equivalents reach an electron transport chain, reducing molecular oxygen. Other forms of cellular respiration use other electron acceptors, so absence of oxygen does not uniquely imply fermentation.^[ref]

The need for NAD+ regeneration follows from a finite-pool argument. In a hypothetical closed preparation with $12\mu \mathrm{mol}$ of initially oxidized NAD+ and no regeneration, at most $6\mu \mathrm{mol}$ of glucose can complete the two NAD+-consuming conversions per glucose. This is an upper bound even with excess glucose, not a predicted stopping time: other limitations can stop the preparation earlier. With an intact fixed nicotinamide adenine dinucleotide pool and no side reactions, converting NAD+ into NADH preserves their sum but depletes the usable oxidized form.

ATP recycling imposes a second condition. Glycolysis needs some initial ATP for investment and consumes two net ADP and two inorganic phosphate per completed glucose. In a closed ideal preparation with only $8\mu \mathrm{mol}$ of initial ADP, no other source of ADP, and enough initial ATP and inorganic phosphate, at most $4\mu \mathrm{mol}$ of glucose can finish. This bound follows from the net ADP consumption, even though investment temporarily produces additional ADP. Initial investment also means that adequate final inventories alone cannot guarantee the route can start.

For continued operation at fixed carrier inventories, other chemical reactions must match the two net ATP formed per glucose with ATP use that restores ADP and inorganic phosphate, or exchange must supply those reactants. ATP hydrolysis coupled to cellular work is one route. Thus glycolysis can sustain useful energy coupling while neither its ATP inventory nor its NADH inventory grows indefinitely; matter cycles while glucose supplies fresh chemical free energy.

Lactic acid is 2-hydroxypropanoic acid, $\mathrm{C}{\mathrm{H}}_3\mathrm{CH}(\mathrm{OH})\mathrm{COOH}$. Its central carbon is a stereogenic centre, and its conjugate base is lactate.

In lactic acid fermentation, reduction of pyruvate to lactate regenerates NAD+ from NADH. That regeneration allows glycolysis to continue when the pathway cannot rely on sufficiently rapid respiratory oxidation of NADH.

A metabolic pathway is a connected sequence of enzyme-catalyzed chemical reactions in metabolism, with a reaction product of one step serving as a substrate for another. A pathway boundary is a choice about which transformations to count: glycolysis ends at pyruvate, whereas subsequent fermentation or cellular respiration changes the final material balance. Adding the individual chemical equations cancels internal intermediates and exposes the net stoichiometry; it does not determine the reaction rate.

A mitochondrion is an organelle with an outer mitochondrial membrane and an inner mitochondrial membrane. The latter encloses the mitochondrial matrix and folds into cristae; the intermembrane space lies on its opposite side. This architecture separates a chemical workspace from a membrane that couples electron transport to ATP formation.^[ref]

For an original location exercise, place soluble label A in the mitochondrial matrix and soluble label B in the interior of a crista. In the depicted geometry, B can reach the peripheral intermembrane space through the fold's opening without crossing a lipid bilayer. A must cross the inner mitochondrial membrane to reach either location. A fold projecting into the mitochondrial matrix therefore does not make its enclosed fluid part of the mitochondrial matrix. Following a continuous path through the colored regions proves the distinction; merely asking whether a label is “inside the mitochondrion” loses it.

The functional connection is equally spatial. The mitochondrial respiratory chain pumps protons from the mitochondrial matrix side across the inner mitochondrial membrane. Their return through ATP synthase can drive ATP formation. Oxidative phosphorylation develops the mechanism and chemiosmosis gives its free energy bookkeeping. Compartmentalization is useful because it lets a shared electrochemical gradient couple different proteins without direct transfer of a chemical intermediate between each pair.

Under aerobic conditions, mitochondria supply much of the ATP in many eukaryotic biological cells; the contribution varies with biological tissue, demand and oxygen supply. Glycolysis also makes ATP in the cytosol. Mature mammalian red blood cells lack mitochondria, and bacteria have no mitochondria at all. Neither all ATP production nor all biological cells fit the familiar mitochondrial picture.^[ref]

Mitochondria descend from a bacterial endosymbiosis and retain a genome and ribosomes, although many required proteins are encoded by nuclear genes. Endosymbiotic theory develops the ancestry argument; organelle protein import explains delivery of nuclear-encoded proteins. A functioning isolated mitochondrion demonstrates biochemical autonomy under supplied conditions, rather than independently establishing that ancestry.

Location determines access to substrates, cofactors and transport routes; identical catalytic potential can therefore serve different physiological functions in different compartments. In carbohydrate metabolism, the plasma membrane, mitochondrion and endoplasmic reticulum are selective barriers, not merely containers. A soluble enzyme cannot use a metabolite efficiently if that metabolite cannot reach its compartment, while transporter abundance matters chiefly when the transporter is in the appropriate membrane.

Most glycolysis occurs in the cytosol, whereas pyruvate dehydrogenase complex and much oxidative metabolism occur in the mitochondrial matrix. Pyruvate entry therefore links cytosolic glucose breakdown to mitochondrial oxidation. Cytosolic NADH does not freely cross the inner mitochondrial membrane: the malate-aspartate shuttle and glycerol phosphate shuttle transfer reducing equivalents through different routes. Their operation affects the energetic outcome of glucose use. In gluconeogenesis, mitochondrial pyruvate carboxylase produces oxaloacetate, but oxaloacetate itself does not freely cross that membrane. Conversion into transportable intermediates, or formation of phosphoenolpyruvate in the appropriate compartment, allows carbon to reach cytosolic steps. Enzyme localization thus imposes an obligatory transport and redox problem, not just an extra reaction label.

At the final step of hepatic glucose production, the catalytic site of glucose-6-phosphatase faces the endoplasmic-reticulum lumen. Glucose-6-phosphate must reach it through the associated transport system. Hydrolysis makes free glucose available for export, whereas the phosphate ester is largely retained by membranes. Muscle can mobilize cytosolic glycogen to glucose-6-phosphate for its own glycolysis, but lacks the hepatic glucose-6-phosphatase system needed for substantial release of that carbon as free blood glucose. Tissue function therefore depends on both enzyme expression and the membrane machinery surrounding the enzyme.

Transporter traffic changes function without waiting for new protein synthesis. In resting muscle and adipose cells, much GLUT4 resides in intracellular vesicles. Insulin signalling promotes its delivery to the cell surface and increases glucose uptake; internalization subsequently reduces surface transport capacity. Classical membrane-fractionation and transport-site measurements supported redistribution from an intracellular pool to the plasma membrane.^[ref] Fractionation requires compartment markers, and surface labelling or microscopy provides an independent check: altered fraction recovery alone could otherwise mimic redistribution. Total cellular GLUT4 is not an adequate proxy for surface uptake capacity.

Polarity provides another example. In intestinal epithelial cells, apical SGLT1 uses the sodium electrochemical gradient to take up glucose, whereas basolateral GLUT2 enables exit towards the circulation. Basolateral sodium-potassium ATPase maintains the sodium gradient. Misplacing a transporter can disrupt vectorial absorption despite normal intrinsic transport activity. Glycogen-associated regulatory enzymes similarly gain access to a localized substrate pool. These examples show why localization should be tested with activity and transport measurements as well as images. Compartmentation creates direction, regulation and tissue specialization, while requiring transporters that connect the separated reactions.

Animal cells conserve part of the free energy from nutrient oxidation in ATP and electrochemical gradients, then couple their consumption to synthesis, transport and movement. The relevant quantity is the actual Gibbs free energy change,where $Q$ is the appropriate reaction quotient, $R$ the molar gas constant and $T$ the absolute temperature. A reaction with a positive free-energy change can proceed when physically coupled to one whose negative change makes the combined process favourable. Merely placing an exergonic reaction nearby does not accomplish coupling: an enzyme, shared intermediate or molecular machine must link the processes.

Oxidation of carbohydrates and fats supplies NADH and other reducing equivalents. In the mitochondrial electron transport chain, transfer towards oxygen releases free energy. Complexes I, III and IV couple electron transfer to proton translocation from the matrix to the intermembrane space; complex II transfers electrons without directly pumping protons. The inner mitochondrial membrane retains the resulting proton-motive force. For movement of one mole of protons from outside to inside, defineHere $F$ is the Faraday constant and $\psi$ is the electrical potential. Both the relatively negative matrix potential and its relatively alkaline pH favour inward movement. An inward driving voltage of magnitude $0.18\mathrm{V}$ corresponds to approximately $17.4\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ per mole of protons. This is an illustrative calculation, not a universal mitochondrial measurement.

Proton movement through ATP synthase drives rotation and conformational changes that couple ADP and phosphate to ATP formation. Several protons are required per ATP, and transport of phosphate and adenine nucleotides adds energetic costs; there is no universal whole-number ATP yield for every animal cell. Reconstitution of a light-driven proton pump with ATP-synthesizing machinery in lipid vesicles showed that an independently generated gradient can support ATP formation. This experiment used an artificial mixture of components, providing a mechanistic test rather than a model of animal-cell photosynthesis.^[ref] In mitochondria, respiratory inhibitors, an ATP-synthase inhibitor and a protonophore give distinct predictions for oxygen consumption, ATP production and the gradient, helping distinguish electron transfer from coupling.

ATP then supplies a mobile chemical coupling intermediate. Transfer of a phosphate group can make an otherwise unfavourable biosynthetic step favourable through a common intermediate. sodium-potassium ATPase couples ATP hydrolysis to ion pumping; sodium-dependent cotransport uses the stored gradient for secondary active transport. Myosin couples its ATPase cycle to force and displacement on actin. Substrate-level phosphorylation also generates ATP directly during glycolysis and other reactions without an obligatory respiratory gradient. ATP hydrolysis is favourable because of the free-energy difference between the full reactant and product states under cellular conditions, not because breaking a bond alone releases energy.

Conversion is never perfectly efficient: heat is produced, proton leak can bypass ATP synthase, and controlled uncoupling can favour heat production. ATP concentration and the ATP/ADP/phosphate ratio reflect a maintained nonequilibrium state. Energy transduction is therefore a chain of coupled chemical, electrical, osmotic and mechanical changes, sustained by metabolism and constrained by thermodynamics.

The liver uses glucose sensing chiefly to regulate fuel storage and production, while pancreatic beta cells convert glucose availability into an endocrine signal. The comparison therefore includes transport, metabolism and allosteric control; it should not identify one transporter as the complete sensor in either tissue.

glucokinase phosphorylates glucose to glucose-6-phosphate in both hepatocytes and pancreatic beta cells. Unlike many other hexokinases, it is not strongly inhibited by its product and operates over a higher glucose range. Its monomeric enzyme nevertheless shows a sigmoidal steady-state response to glucose, arising from its kinetic conformational behaviour rather than cooperative binding between several subunits. A glucose half-saturation concentration in the physiological millimolar range makes its flux responsive to changing blood glucose, whereas a low-affinity constant cannot alone establish the in vivo sensing step without considering transport and downstream metabolism.

In beta cells, glucose metabolism through glycolysis and mitochondrial oxidation increases the cellular ATP-to-ADP state. ATP-sensitive potassium channels then close: ATP inhibits the Kir6.2 pore, while Mg-nucleotide effects mediated through SUR1 additionally regulate opening. Reduced potassium conductance produces depolarization, opening voltage-gated calcium channels. Calcium entry triggers exocytosis of insulin-containing secretory granules. Thus the channel senses nucleotides downstream of glucose metabolism; it does not bind extracellular glucose as its initiating ligand. Metabolic amplification and other signals also regulate the amount secreted, so this triggering pathway is necessary context rather than a complete description of every phase of insulin secretion.

glucokinase helps set the glucose threshold for that response. An activating glucokinase mutation associated with familial hyperinsulinism provides evidence that shifting the enzyme's glucose responsiveness can shift whole-body insulin control.^[ref] To separate this interpretation from altered expression, the variant's kinetics should be compared with the normal enzyme and its effect on secretion assessed at matched expression. Inhibiting the potassium channel downstream can bypass part of the sensing chain, whereas preventing calcium entry tests the final electrical-to-secretory coupling.

Glucose transport must be discussed with species in mind. GLUT2 is the prominent transporter in the classical rodent beta-cell model, but human beta cells use predominantly GLUT1 rather than sharing the same abundance of GLUT2. Direct comparison of human and rat preparations found much lower GLUT2 abundance in human cells while glucokinase retained a comparable influence on glucose utilization.^[ref] A transport step with capacity greater than phosphorylation can allow intracellular glucose availability to track the external supply, leaving glucokinase as a major metabolic control point. These observations argue against presenting rodent GLUT2 expression as a universal human sensing mechanism.

In the liver, GLUT2 supports rapid bidirectional facilitated transport. Hepatic glucokinase traps abundant glucose as glucose-6-phosphate, supplying glycogenesis and other metabolic pathways after feeding. glucokinase regulatory protein adds tissue-specific control: at low glucose it binds and sequesters glucokinase in the nucleus; increased glucose promotes release and cytoplasmic use. fructose-6-phosphate favours the inhibitory interaction, while fructose-1-phosphate antagonizes it, coordinating glucose trapping with nutrient context. Hormonal regulation of glucokinase expression adds a slower level of control. Unlike the beta-cell response, the immediate output is a change in hepatic metabolic flux, not release of insulin.

The liver also has an important direct glucose sensor in glycogen phosphorylase. Binding of glucose to liver glycogen phosphorylase a favours an inactive conformation and its dephosphorylation by protein phosphatase 1. Loss of phosphorylase-a activity switches off glycogenolysis and relieves its inhibitory influence on glycogen-synthase phosphatase activity, helping activate glycogen synthase. Glucose administration experiments observed phosphorylase inactivation preceding synthase activation, supporting an ordered switch rather than simultaneous independent responses.^[ref] This direct allosteric route is distinct from glucokinase-mediated metabolic sensing and complements insulin signalling. Together they suit an organ that must stop exporting and begin storing glucose when supply rises, while beta-cell sensing coordinates that transition across multiple tissues.

cancer largely reuses normal cellular machinery, but its organization and evolutionary behaviour are not adequately described as one homeostatic control simply being turned up or down. Growth, survival, metabolism, plasticity and tissue remodelling all have normal functions. Malignancy arises when their coordination with the needs of the organism is lost, and selection can then generate new combinations, altered molecular activities and pathological ecological interactions.

Normal proliferation depends on extracellular signals and internal cell-cycle controls. Constitutive receptor or Ras signalling, increased cyclin activity or weakened RB–E2F restraint can make a biological cell divide under conditions in which its neighbours would arrest. These changes exploit existing DNA replication and mitotic machinery rather than inventing a new way to duplicate a genome. Equally, normal apoptosis removes damaged or inappropriate biological cells; a tumour can survive by suppressing this response. Loss of p53 can compromise a network linking stress to arrest, repair, death and other restraints. Mice lacking p53 develop spontaneous tumours despite largely normal development, directly demonstrating the importance of an existing protective programme.^[ref] This does not mean that every cancer must eliminate every p53 output or that all p53 mutations have the same effect.

Many other properties have similarly recognizable antecedents. glycolysis, nutrient uptake and autophagy support normal growth and stress adaptation; their deployment can help cancer biological cells tolerate fluctuating resources. Angiogenic signals normally support development and repair, but sustained production can recruit vessels into a growing tumour. Motility, matrix remodelling and reversible changes in adhesion participate in development and wound repair. cancer can recruit them for invasion, with surrounding fibroblasts and immune biological cells contributing signals and physical routes. Collective breast-cancer invasion, for example, can depend on a conserved basal epithelial programme rather than a completely new locomotor apparatus.^[ref] Immune suppression also uses normal regulatory pathways, although suppressing antitumour immunity conflicts with organismal protection.

The homeostatic interpretation is most useful when it emphasizes constraints and feedback. Normal tissue renewal couples production to biological cell loss and spatial organization. A mutation increasing division, reducing death or changing competitive interactions can unbalance this system even without maximal activation of every pathway. Selection acts on net clonal success, not only on instantaneous proliferation. A slowly cycling population that survives therapy or colonizes a new site may be favoured under particular conditions. Conversely, an excessively strong oncogenic signal can trigger senescence or apoptosis, so successful cancers often combine activating changes with escape from compensating restraints. Different combinations can converge on similar phenotypes.

However, “nothing new” becomes misleading at the molecular level. Some alterations generate a qualitatively changed activity. Cancer-associated IDH1 mutants acquire the ability to reduce alpha-ketoglutarate to R-2-hydroxyglutarate, rather than simply increasing the enzyme's ordinary reaction. metabolite profiling and biochemical assays established this altered catalytic activity.^[ref] gene fusions can join recognition and signalling domains in new regulatory arrangements, while new enhancer contacts or altered splicing can change which molecular combinations are expressed. These innovations still obey familiar chemistry and use inherited components, but that is true of biological innovation generally; it does not make them equivalent to a reversible normal homeostatic response.

cancer is also an evolving population within a changing environment. Genetic and epigenetic variation permit selection for survival during hypoxia, immune attack or treatment. The selected phenotype can depend on the surrounding stroma and on interactions among tumour subclones. Normal wound-healing responses may stop when repair is complete, whereas a tumour can maintain the signals or continually regenerate the damage that recruits them. Altered metabolism, inflammation and genomic instability can create feedback that changes the environment itself. This is not a single biological cell merely ignoring one stop signal, and one successful clone need not benefit either neighbouring cancer biological cells or the host.

Experimentally, the distinction matters. If an existing normal programme is misregulated, correcting the upstream input or restoring feedback may normalize behaviour, but normal tissues using the same programme may also be affected. If an altered protein has a tumour-specific pocket or catalytic dependence, that difference may provide selectivity. Genotype-matched perturbations, measurements of the normal counterpart and tests in tissue context discriminate these cases. A list of cancer-associated phenotypes alone does not determine whether the causal change is quantitative, qualitative or ecological. cancer usually repurposes normal processes, but malignancy emerges from altered control, molecular changes and selection among biological cells; “simply deregulation” understates that causal complexity.

The historical name fermentation covered several transformations of organic matter: alcoholic, lactic, butyric and acetous changes, as well as some processes now classified separately. In modern biochemistry, fermentation more narrowly means energy-yielding metabolism that regenerates oxidized cofactors without requiring an external respiratory electron acceptor. The older use of the word should not be forced into that modern definition.

In alcoholic fermentation, suitable yeast converts a fermentable sugar into ethanol and carbon dioxide. For glucose, the principal net balance isA vessel with an outlet for the evolved gas and a separate receiver illustrates the change: test the carbon dioxide with limewater and identify the volatile alcohol in a separated distillate. Gas evolution alone does not prove that the liquid contains ethanol. Actual yeast cultures also make biomass and minor products; the chemical equation describes the principal conversion. In modern terms, glycolysis supplies ATP, and the reduction leading to ethanol regenerates NAD+ from NADH.

In lactic acid fermentation, an ideal homolactic balance isThe souring of suitable carbohydrate-containing materials, including milk, supplied a familiar historical example. Hydrolysis of lactose supplies monosaccharides, while acid production lowers the pH and can precipitate casein. Casein coagulation is a consequence of the changed conditions, not evidence that the protein has itself been converted into lactic acid. Some organisms instead make additional products, so not every lactic fermentation obeys only this homolactic balance.

In butyric acid fermentation, carbohydrates or lactate can give butyric acid, carbon dioxide and molecular hydrogen. An idealized balance from lactic acid isIt contrasts with the simple homolactic balance because both gaseous products and a different organic acid appear. Mixed cultures and alternative pathways can alter the product distribution; odour is neither a sufficiently specific nor a necessary laboratory test.

Acetous fermentation denotes the conversion of ethanol into acetic acid, as in vinegar production:It depends on oxygen and is now understood as an aerobic microbial oxidation, rather than a fermentation in the narrow biochemical sense. This explains why access to air matters differently here than in the main alcohol-producing stage.

Other older extensions of the word include saccharification or diastatic changes, such as the hydrolysis of starch into smaller sugars by malt enzymes, and sugar inversion, in which sucrose takes up water to form glucose and fructose:The two hexose products have the same elemental formula but different structures. Such hydrolyses prepare substrates for later metabolism; they do not by themselves constitute the alcohol-producing conversion. Viscous fermentation or mucilaginous fermentation described transformations yielding gum-like material and sometimes mannitol; it is an operational historical category without one universal balanced chemical equation. Putrefactive fermentation referred to the decomposition of nitrogen-containing organic matter, including proteolysis and subsequent reactions producing Ammonia, amines and sometimes hydrogen sulfide. It likewise has no single formula covering every mixed substrate and product.

The unifying historical interest is that small amounts of a “ferment” bring about major changes in a large amount of organic substrate. Modern explanation distinguishes organisms, enzymes and metabolic pathways. The later demonstration of fermentation in cell-free yeast juice showed that alcoholic conversion need not require intact living yeast cells in the reacting liquid; that result belongs to 1897, not to knowledge to demand of an 1866 candidate.^[ref]

Phosphoenolpyruvate supplies a phosphate group to ADP in the final glycolysis step catalyzed by pyruvate kinase. The free ionic form used in the worked balance has charge $-3$.

Phosphoenolpyruvic acid is the acid form of phosphoenolpyruvate, a phosphorylated enol derivative of pyruvic acid. Its phosphate group is attached through oxygen to the enol system.

In glycolysis, transfer of that phosphate group to ADP forms ATP and pyruvate. Conversion of the initial enol product into the more stable keto form helps favour the overall reaction, connecting molecular rearrangement with energy transfer.

The pyruvate dehydrogenase complex converts pyruvate into acetyl-CoA, releasing carbon dioxide and reducing NAD+ to NADH. Several catalytic components and enzyme cofactors couple decarboxylation, group transfer and oxidation within one assembly. It links glycolysis to the citric acid cycle, so control of the complex regulates the entry of carbohydrate-derived carbon into oxidative metabolism. A shared reaction intermediate can be passed between component active sites rather than diffusing freely through the cell. ^[ref]